Lipid management for primary and secondary stroke prevention consensus paper of the International Lipid Expert Panel (ILEP)
Evaluating the impact of communicating high polygenic risk for coronary artery disease on the health behaviour of young overweight adults: a pragmatic randomised controlled trial
Stroke Action Plan for Europe 2018-2030 (SAP-E): mid-term review and update.
Preliminary results of the evaluation of pharmacokinetic profiles in Haemophilia A patients receiving Efanesoctocog Alfa
Consistency and Within-Subject Variation in the Interpretation of von Willebrand Factor Multimers Using Semi-Automated Hydragel Assay
Performance Evaluation of a One-Stage Clotting Assay in Monitoring Efanesoctocog Alfa Activity: Insights from the ECAT 2024 Survey
Overweight, obesity, and cardiovascular disease in heterozygous familial hypercholesterolaemia: the EAS FH Studies Collaboration registry.
In vitro adsorption of direct oral anticoagulants from patient plasma samples
Vascular calcification inhibitors in chronic kidney disease
Implementation of laboratory approach for persons with hemophilia requiring DOAC therapy.
Tavapraktikal põhinev tervishoiuteadus: lühiülevaade pragmaatilistest uuringutest
Laboratory Options for Assessing the Effects of Direct Oral Anticoagulants in Estonia
Nicotine from a Different Angle: Biological Effects from a Psychoneuroimmunological Perspective
The European Program for Prevention (EPP) – Implementing Proven Preventing Measures Now!